Bio-Path Hldgs: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Bio-Path Holdings (NASDAQ:BPTH) reported Q3 earnings with an EPS of $-0.32, beating estimates by 5.88% but with no change in revenue from the same period last year. Despite missing EPS last quarter, the share price increased by 7.92% the following day.
November 15, 2023 | 11:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bio-Path Holdings reported better-than-expected Q3 earnings, with an EPS of $-0.32 against an estimate of $-0.34, but no revenue growth from the same period last year.
Beating earnings estimates typically has a positive impact on stock prices in the short term. However, the lack of revenue growth may temper investor enthusiasm. Historical data shows a share price increase following an earnings miss last quarter, suggesting a positive investor sentiment towards BPTH's earnings reports.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100